Medical devices, healthcare technology and the business of care
510(k) clearance · K253512

MiniMed Go App

Medtronic Minimed · Decision date Jan 8, 2026

FDA DECISIONK253512

What did the FDA decide?

FDA records K253512 as a 510(k) premarket notification, with a decision dated Jan 8, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Anesthesiology
Decision date
Jan 8, 2026

FDA source record

Regulatory record facts

Identifier
K253512
Regulatory pathway
510(k) premarket notification
Product code
NDC
Decision code
SESE
Decision date
Jan 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Calculator, Drug Dose.

Product code
NDC
FDA device class
2

FDA decision timeline

  1. K253512 received

    Application receipt date recorded by FDA.

  2. K253512 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NDC

Product / regulatory recordCompanyPathwayDecision dateSource
Glytec, LLC510(k) clearanceOct 5, 2026FDA
Glytec, LLC510(k) clearanceMay 27, 2026FDA
Glooko, Inc.510(k) clearanceMay 1, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Minimed

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
Los Angeles, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records